ZEB1 and primary cutaneous T-cell non-Hodgkin lymphoma: In CTCL, ZEB1 acts as a transcriptional repressor contributing to an oncogenic regulatory mechanism involving IL15, HDAC1, HDAC6, and miR-2116.